Results
1486
Companies which are more than 50% undervalued based on analyst price target.
1,486 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LOBO | US$1.23 | -18.0% | n/a | US$11.2m | US$4.00 | PE1140.7x | S41.6% | n/a | Automobiles | ||
SSKN | US$2.64 | -1.1% | -48.3% | US$11.0m | US$11.00 | PS0.3x | E62.5% | n/a | Healthcare | ||
LUCY | US$3.90 | -8.5% | -48.7% | US$11.0m | US$14.00 | PS6.1x | S181.4% | n/a | Healthcare | ||
ALUR | US$2.85 | -15.7% | -96.2% | US$10.9m | US$28.67 | PS0.3x | E24.9% | n/a | Consumer Services | ||
PRPH | US$0.42 | -21.9% | -91.0% | US$10.7m | US$13.80 | PS0.8x | E81.4% | 0% | Pharmaceuticals & Biotech | ||
BNZI | US$1.26 | -22.7% | -96.4% | US$10.5m | US$30.00 | PS2.1x | E98.3% | n/a | Software | ||
BRTX | US$1.51 | -5.6% | 7.9% | US$10.5m | US$13.00 | PS27.7x | E64.1% | n/a | Pharmaceuticals & Biotech | ||
UGRO | US$0.80 | 4.5% | -60.1% | US$10.5m | US$3.57 | PS0.2x | E66.2% | n/a | Capital Goods | ||
MYNZ | US$5.07 | -10.4% | -85.8% | US$10.5m | US$14.00 | PS11.1x | E18.5% | n/a | Pharmaceuticals & Biotech | ||
RVSN | US$0.52 | -20.2% | -76.2% | US$10.4m | US$7.00 | PS11.6x | S182.9% | n/a | Tech | ||
GREE | US$0.81 | -23.6% | -79.0% | US$9.9m | US$4.00 | PS0.1x | E-15.6% | n/a | Software | ||
SBEV | US$0.15 | -3.6% | -73.9% | US$9.9m | US$1.00 | PS1.5x | E0.5% | n/a | Food, Beverage & Tobacco | ||
KNWN.D | US$3.74 | 18.7% | -89.6% | US$9.9m | US$40.00 | PE-0.6x | E-12.1% | n/a | Healthcare | ||
PNST | US$0.18 | -39.3% | -95.2% | US$9.8m | US$2.00 | PS0.06x | E-35.8% | n/a | Consumer Services | ||
SDCH | US$0.042 | -7.0% | -10.8% | US$9.8m | US$0.23 | PS1.3x | E157.9% | n/a | Software | ||
KPRX | US$3.07 | -8.4% | -47.5% | US$9.8m | US$18.50 | PE1.7x | E0.2% | n/a | Pharmaceuticals & Biotech | ||
TRUG | US$0.38 | -22.8% | -68.0% | US$9.7m | US$2.50 | PS0.4x | E58.0% | n/a | Media | ||
EVOK | US$3.62 | -25.1% | -54.6% | US$9.6m | US$18.00 | PS0.9x | E124.7% | n/a | Pharmaceuticals & Biotech | ||
TLPH | US$0.54 | -0.4% | -58.5% | US$9.5m | US$4.17 | PS32.7x | E46.9% | n/a | Pharmaceuticals & Biotech | ||
XTIA | US$2.62 | -23.4% | n/a | US$9.5m | US$13.50 | PS4x | E6.0% | n/a | Software | ||
ULY | US$0.72 | 52.5% | -75.3% | US$9.3m | US$1.50 | PE0.1x | E-13.0% | n/a | Software | ||
RYDE | US$0.34 | -4.6% | n/a | US$9.3m | US$2.00 | PS1.5x | E53.1% | n/a | Transportation | ||
JTAI | US$6.34 | 7.8% | -96.8% | US$9.2m | US$20.00 | PS0.5x | E17.3% | n/a | Transportation | ||
BCDA | US$2.56 | 19.1% | -62.5% | US$9.2m | US$15.50 | PS165.3x | E-15.7% | n/a | Pharmaceuticals & Biotech |